Published online before print December 19, 2005, doi: 10.1161/CIRCULATIONAHA.105.580696
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2006;113:30-37.)
© 2006 American Heart Association, Inc.
Epidemiology |
Distribution of Coronary Artery Calcium by Race, Gender, and Age
Results from the Multi-Ethnic Study of Atherosclerosis (MESA)
From the Department of Biostatistics, University of Washington, Seattle (R.L.M., H.C., R.A.K.); Division of Cardiology, Harbor–UCLA Medical Center, Los Angeles, Calif (R.D.); and Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, Md.
Correspondence to Robyn McClelland, Collaborative Health Studies Coordinating Center, Department of Biostatistics, University of Washington, Bldg 29, Suite 310 6200, NE 74th St, Seattle, WA 98115. E-mail rmcclell{at}u.washington.edu
Received August 3, 2005; revision received October 12, 2005; accepted October 31, 2005.
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Background— Coronary artery calcium (CAC) has been demonstrated to be associated with the risk of coronary heart disease. The Multi-Ethnic Study of Atherosclerosis (MESA) provides a unique opportunity to examine the distribution of CAC on the basis of age, gender, and race/ethnicity in a cohort free of clinical cardiovascular disease and treated diabetes.
Methods and Results— MESA is a prospective cohort study designed to investigate subclinical cardiovascular disease in a multiethnic cohort free of clinical cardiovascular disease. The percentiles of the CAC distribution were estimated with nonparametric techniques. Treated diabetics were excluded from analysis. There were 6110 included in the analysis, with 53% female and an average age of 62 years. Men had greater calcium levels than women, and calcium amount and prevalence were steadily higher with increasing age. There were significant differences in calcium by race, and these associations differed across age and gender. For women, whites had the highest percentiles and Hispanics generally had the lowest; in the oldest age group, however, Chinese women had the lowest values. Overall, Chinese and black women were intermediate, with their order dependent on age. For men, whites consistently had the highest percentiles, and Hispanics had the second highest. Blacks were lowest at the younger ages, and Chinese were lowest at the older ages. At the MESA public website (http://www.mesa-nhlbi.org), an interactive form allows one to enter an age, gender, race/ethnicity, and CAC score to obtain a corresponding estimated percentile.
Conclusions— The information provided here can be used to examine whether a patient has a high CAC score relative to others with the same age, gender, and race/ethnicity who do not have clinical cardiovascular disease or treated diabetes.
Key Words: arteries • calcium • epidemiology • imaging
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Coronary artery calcium (CAC) has been demonstrated to be associated with the risk of coronary heart disease. The most frequently used measure in the literature is the Agatston score, which measures the amount of calcium at each lesion scaled by an attenuation factor and summed over all lesions.1 Often, cut points are used to define a "high" CAC score that do not have a formal basis on the distributional nature of CAC, either as a predictor of events or in a healthy population (eg, CAC >100). The same cut points often are used for men and women and for young and old.2 Bild et al3 have shown that coronary calcium prevalence and amount in the Multi-Ethnic Study of Atherosclerosis (MESA) are heavily influenced by ethnicity, in addition to age and gender. MESA provides a unique opportunity to examine the distribution of CAC on the basis of age, gender, and race/ethnicity in a cohort free of clinical cardiovascular disease and treated diabetes. These distributions can aid in the clinical interpretation of observed CAC scores and can provide guidance to researchers as to what constitutes high CAC scores in individuals of different gender, ethnicity, and age.
Clinical Perspective p 37
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Study Participants
MESA is designed to study the prevalence, risk factors, and progression of subclinical cardiovascular disease in a multiethnic cohort. A detailed description of the study design and methods has been published previously.4 Briefly, 6814 participants 45 to 84 years of age who identified themselves as white, black, Hispanic, or Chinese were recruited from 6 US communities from 2000 to 2002. All participants were free of clinically apparent cardiovascular disease (physician-diagnosed heart attack, angina, stroke, transient ischemic attack, or heart failure; current atrial fibrillation; taking nitroglycerin; or having undergone angioplasty, coronary artery bypass graft, valve replacement, pacemaker or defibrillator implantation, or any surgery on the heart or arteries). Other exclusions included pregnancy, active treatment for cancer, weight >300 pounds, cognitive inability as judged by the interviewer, living in a nursing home or on the waiting list for a nursing home, plans to leave the community within 5 years, language barrier (speaks a language other than English, Spanish, Cantonese, or Mandarin), CT scan of the chest within past year, or any serious medical condition that would prevent long-term participation. The communities were Forsyth County, North Carolina; Northern Manhattan and the Bronx, NY; Baltimore City and Baltimore County, Maryland; St Paul, Minn; Chicago, Ill; and Los Angeles County, California. The source population for each field center varies in size and ethnic composition. Each field center developed its sampling frame and recruitment procedures according to the characteristics of its community and available resources, including lists of residents, dwellings, telephone exchanges, Division of Motor Vehicle lists, consumer lists, voter registration lists, and census data. Selection from the sampling frames used simple random samples from the lists and random-digit dialing or proceeded sequentially through predefined neighborhoods. Multiple eligible participants residing in a single household were allowed to participate. Each site recruited an approximately equal number of men and women according to prespecified age and race/ethnicity proportions. All participants gave informed consent. For the present analysis, we excluded subjects with treated diabetes at baseline because this condition is known to be associated with much higher calcium levels. This allows us to estimate CAC percentiles from a cohort that is relatively healthy in terms of their risk factors for CAC.
Measurement of CAC
CAC was measured with either electron-beam computed tomography (EBT) at 3 field centers or multidetector computed tomography (MDCT) at 3 field centers. Each participant was scanned twice consecutively, and these scans were read independently at a centralized reading center. The methodology for acquisition and interpretation of the scans has been documented previously.5 The results from the 2 scans were averaged to provide a more accurate point estimate of the amount of calcium present. The amount of calcium was quantified with the Agatston scoring method.1 Calcium scores were adjusted with a standard calcium phantom that was scanned along with the participant.6 The phantom contained 4 bars of known calcium density. This phantom provides a way of calibrating the degree of brightness between sites and participants. Rescan agreement was found to be high with both EBT and MDCT scanners.7 Interobserver agreement and intraobserver agreement were found to be very high (
=0.93 and 0.90, respectively).
Statistical Analysis
The distribution of baseline CAC in a sample free of clinical cardiovascular disease is heavily skewed, with &50% of participants having zero calcium. The positive portion of the CAC distribution is fairly symmetric and bell shaped on the log scale. As a first step in obtaining the desired percentiles of the overall distribution, we model the mean of the log CAC distribution nonparametrically as a function of age for each gender and race using a local regression smoother with a smoothing span of 0.7.8 For each observation in the positive log-transformed CAC distribution, we subtract the corresponding estimated value. The pooled residuals from this model are then ranked, and we calculate the jth percentile for each of j=1...100 of the residuals. Adding these to the fitted value for a particular age, gender, and race yields an estimated percentile for the log-transformed positive CAC variable (see the article by O’Brien and Dyck9 for details on this method). Taking the exponential of this percentile yields the jth percentile of the positive portion of the CAC distribution. If a certain proportion (p) has zero calcium, then the jth percentile calculated above is the 100x{p+[(1–p)j]/100} percentile of the overall distribution. We model p as a nonparametric function of age by fitting a local regression smoother within each gender and race. Thus, we estimate the percentiles of the whole distribution as a function of the percentiles of the positive calcium scores, and the process does not involve any parametric assumptions. All calculations were performed with R, version 2.0.1.10
A common approach taken in the literature is to categorize age and then simply calculate the empirical percentiles within each age/gender/race stratum. The nonparametric modeling approach described above has several advantages in that we can consider age as a continuous variable, and by using the pooled residual distribution (after accounting for age, gender, and race), we have substantially more precision to estimate the percentiles. Additionally, we do not use an assumption of a normal distribution in the above calculations, which is important, particularly because the upper percentiles are of primary interest and estimated percentiles derived based on a normal assumption are much better in the central portion of the distribution than in the tails.
As a final analysis, we repeated the percentile estimation on an extremely healthy subset of our MESA cohort. For this purpose, we restricted the analysis to nondiabetics with a 10-year Framingham risk of <10%.11 For these calculations, the sample sizes were more limited, and we were not able to do race-specific models. Instead, we used a shift model for race (eg, main effect of race only) within each gender. Thus, race effects could be different for men and women but were constant across age.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Table 1 presents the characteristics of our study sample. After exclusion of 704 subjects (680 treated diabetics, 24 with unknown diabetes status), 6110 subjects remained for analysis, with 53% female and an average age of 62 years. The race/ethnicity distribution was balanced across gender by design, with 41% white, 11.8% Chinese-American, 26.4% black, and 20.9% Hispanic. Approximately half the cohort had never smoked, 13% were current smokers, 42.0% had a history of hypertension (defined as diastolic blood pressure
90 mm Hg, systolic blood pressure 140 mm Hg, or use of antihypertensive medications), and 32.4% had dyslipidemia (defined as ratio of total cholesterol to HDL >5.0 or taking a lipid-lowering medication). More than two thirds of subjects were overweight or obese (body mass index >25 kg/m2) according to World Health Organization (WHO) guidelines, 58.7% had a household income below $50 000 per year, and 17% had not completed high school. A greater proportion of women were extremely overweight (5% versus 1.2% for men with body mass index >40 kg/m2).
|
As previously described, men had higher calcium scores than women, and the amount and prevalence of calcium increased steadily with age. Almost two thirds of women (62%) had calcium scores of zero in this sample, as opposed to 40% of men. Figure 1 displays the probability of a positive CAC score for each gender and race as a function of age. The solid line represents a local regression smoother applied to the raw data. The individual points represent the observed age-specific proportion, with point size reflecting the available sample size at that age (larger points indicate more subjects). Although overall the relationship between the probability of any detectable calcium and age was linear, there were certain gender/race subgroups for which there was discernible nonlinearity. Age relationships for men tended to be concave down (increasing more quickly); for women, they tended to be concave up (increasing more slowly). This was particularly true for white men (who had the highest rate of nonzero calcium) and black or Hispanic women (who had the lowest rate of nonzero calcium). Because neither a linear nor a logistic curve could capture this nonlinearity, a fully nonparametric fit was used. Differences between men and women were greater for whites, particularly in the middle of the age range in which the differences in concavity are most apparent. Hispanic women had the lowest prevalence of nonzero CAC, whereas white women had the highest. Chinese and black women were intermediate, with their order varying, depending on age. Overall for men, blacks had the lowest prevalence of CAC, although in the highest age group (75 to 84 years), Chinese men had the lowest. Similar to women, white men had the highest prevalence of calcium. White men virtually all had calcium by 80 years of age, whereas &20% of Chinese men were free of calcium at 80 years of age. Hispanic and black men were intermediate, with &10% remaining free of calcium at 80 years of age.
|
Table 2 displays various estimated percentiles by 10-year age group, gender, and race/ethnicity. For these calculations, the percentile was estimated at the midpoint of the age range. This table underscores the importance of considering race/ethnicity, in addition to age and gender, when interpreting calcium scores. As Bild et al3 pointed out, there are significant age-by-ethnicity interactions with respect to calcium score. For women, whites had the highest percentiles and Hispanics generally had the lowest, although again in the oldest age group, the Chinese women had the lowest values. Overall, Chinese and black women were intermediate, with their order dependent on age. For men, whites consistently had the highest percentiles, and Hispanics had the second highest (in contrast to women). Blacks were lowest at the younger ages, and Chinese were lowest at the older ages. For instance, for those 75 to 84 years of age, the estimated percentiles for white men were &4 times higher than that for Chinese men in the same age range. Further distributional details may be obtained at the MESA public website (http://www.mesa-nhlbi.org), where an interactive form allows one to enter an age (in years), gender, and race/ethnicity (for the 4 race/ethnicity groups included in MESA) and obtain a corresponding set of estimated percentiles.
|
Figures 2 and 3
show the percentile curves for each combination of gender and race/ethnicity as a function of age. Each plot shows the estimated curves for the 50th, 75th, and 90th percentiles of calcium across age. The observed empirical percentiles for each 5-year age interval also appear on the plot for reference. In Figure 4, we provide a set of curves showing a possible upper cut point of calcium distribution. Note that the y axis scales are very different for the 2 genders. With this format, it is easier to compare the races and to determine at a glance what an approximate 90th percentile is for a particular patient. The age interactions are easily visible in this plot. At older ages (above &70 years of age for men and 75 years of age for women), the Chinese had the lowest values. At younger ages, the lowest values were for Hispanic women and black men. Whites were consistently much higher than the other 3 races.
|
|
|
We explored the question of whether the 2 different types of scanners (EBT and MDCT) result in a similar distribution of CAC scores (data not shown). We found that the estimated percentiles are very similar between EBT and MDCT. Specifically, we looked at quantile-quantile plots within each race, and the results were very linear along y=x, indicating that the quantiles for the EBT measurements are very close to the quantiles for MDCT measurements. Additionally, regression models for log calcium as a function of scanner type indicated no large or statistically significant impact of scanner type on average log calcium.
Although we have presented results for phantom-adjusted CAC, these scores are very similar to unadjusted calcium scores and are strongly related to volume scores. In Figure 5, we show a scatter plot of the relationships and accompanying linear regression curve that could be used to approximately calibrate either form of the scale to the phantom-adjusted scale to use our reported percentiles. In virtually all cases, a zero for the CAC volume score or for the unadjusted Agatston score will translate to a zero score after phantom adjustment; hence, these regression lines were estimated only for those with positive scores. For the Agatston score, the observed score could simply be used as though it were a phantom-adjusted CAC score because the line has roughly unit slope with zero intercept. For CAC volume, the observed score should be inflated according to the equation provided.
|
In Figure 6, we compare our estimated 50th and 90th CAC percentiles with those reported from the recently published Heinz Nixdorf Recall Study, a population-based study conducted in Germany. These estimates are very comparable for both men and women regardless of age.
|
Table 3 displays reference values for a very healthy subset of the MESA cohort, specifically nondiabetics with 10-year Framingham risk <10%. This subset consisted of 3586 participants, of whom 1208 (33.7%) had positive CAC scores. Only 917 (26%) of this healthy subset were men. Estimation at the older ages was not possible because of small sample sizes. For women, estimated percentiles were very similar for this healthy subset compared with the general (nondiabetic) MESA population. For men, the percentiles tended to be lower for the healthy subset as expected, although they were actually somewhat higher for Chinese for the 55- to 64-year-old group. Because we were unable to estimate a race-specific model within the healthy subset, information is borrowed from the other races to estimate the age effect.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
MESA provides a unique opportunity to establish age-, gender-, and race/ethnicity-specific percentiles for CAC in a cohort that is free of symptomatic clinical cardiovascular disease and treated diabetes. Unlike most previously published reference studies of CAC, MESA participants are not referred for CAC measurement, and 4 race/ethnic groups are represented. We observed substantial differences among the 4 race/ethnicity groups in terms of CAC distribution, as well as significant interactions of both age and gender with race/ethnicity. These results underscore the importance of factoring race into the estimation of reference ranges for CAC. A previous MESA publication3 found that overall blacks tended to have the lowest calcium prevalence and levels; however, these analyses were adjusted for a number of other risk factors to understand the independent contributions of race.
The percentiles estimated in MESA for whites are very similar to those recently published from the Heinz Nixdorf Recall Study in Germany.12 This population-based study excluded subjects with a history of coronary artery bypass surgery, revascularization, or myocardial infarction. They did include 6% diabetics, however, which may have resulted in slightly higher percentiles. Previous studies have presented age- and gender-specific percentiles for asymptomatic subjects13–16 using either self-referred or physician-referred patients. Comparing the MESA estimated median and 75th and 90th percentiles with these previous studies (using our estimates for whites) showed that our values were somewhat lower over most of the age range and somewhat higher at the oldest ages (data not shown). Similar findings were reported by Schmermund et al12 for the Heinz Nixdorf Recall Study; they observed an approximate 5-year shift in CAC values between their population-based study and previously published referral-based studies.
We found no difference in calcium percentiles between EBT and MDCT measurements. In this study, we used phantom-adjusted values. Calcium scores were adjusted by use of a standard calcium phantom (with 4 bars of known calcium density) that was scanned along with the participant. This phantom provided a way of calibrating the degree of brightness between sites and hence different scanner types, which may explain why there was so little difference by scanner type in our data.
The MESA estimates are smooth over the age range because of the manner in which we have estimated our percentiles. Unlike empirical percentiles, which may overfit the data when the sample size is small, our smoothing approach estimates the percentiles from the shape of the distribution observed over the whole age range. This approach results in the higher estimated percentiles compared with previous studies at the oldest age range. In addition to having the smallest sample sizes, the oldest age range is most affected by the survivor bias in the studies, which results in lower-than-expected empirical percentiles. Our smoothing approach provides more realistic estimates for the general population.
The estimated percentiles obtained on the low-risk subset of MESA (Table 3) can, in some senses, be regarded as target values. For the oldest age groups, there were very few low-risk subjects; hence, percentiles from the whole MESA population could be used as the reference values. Even for the lower age groups, the percentiles were quite similar, especially for women, so it may be preferable to simply refer to the whole (nondiabetic) sample estimates (Table 2 and figures) because they are estimated from a larger sample size that permitted race-specific effects. This is not surprising in that traditional cardiovascular risk factors are not strongly predictive of the amount of CAC (given that some calcium is present), despite CAC being a strong predictor of CHD events. In particular, it has been shown that CAC is significantly associated with incident events even after controlling for Framingham Risk Score17 and hence reflects, to some extent, a different component of the disease process.
Our study has some limitations that should be noted. The MESA sample is not truly a random sample of individuals (subjects were recruited with a variety of methods),4 and people who agree to participate in research studies generally tend to be healthier overall than the general population. However, the similarity of our estimated percentiles with those from the Heinz Nixdorf Recall study, conducted on a European population, suggests that the results are quite generalizable. Although our ability to estimate the CAC distributions for Chinese participants is unique, only 12% of our cohort was Chinese, so these estimates are more variable than those for the other race/ethnicities. Additionally, there are some differences in scanning methodology between our study and previously published studies. Two scans were obtained and averaged for each participant in MESA, which could increase the prevalence of nonzero calcium compared with obtaining a single scan. The field of view for the MESA scans was 350 mm, which is larger than previous studies, resulting in larger pixels. We also required calcium to be present in 4 adjacent pixels to register as a calcified area, whereas other studies required between 2 and 4 pixels. The combination of these factors implies that the calcium measured following the MESA protocol may tend to be lower than that found in previous studies. Finally, the scanning protocol for MESA was designed for research rather than clinical purposes. Thus, it involved a careful screening out of noise from the images, as well as a high degree of standardization in terms of scanning settings and reading. Scans obtained in a clinical setting may have slightly different properties.
Interpretation of specific calcium scores at this time is a challenging problem. Rumberger et al18 suggested cut points for CAC based on maximizing sensitivity and specificity for CAC as a predictor of stenosis in a sample of subjects undergoing both angiography and EBCT. Because this is based on patients undergoing angiography, the cut points obtained by such a method will be high and, if used in practice, may miss disease in the low to moderate ranges. Additionally, age, gender, and race were not factored in. Rumberger et al have made additional recommendations for specific cut points for mild, moderate, and severe CAC that have been used frequently in clinical practice.19 The ACC/AHA Expert Consensus Document2 states that a zero calcium score makes the presence of atherosclerotic plaque very unlikely and may be consistent with a low risk of a cardiovascular event in the subsequent 2 to 5 years. In contrast, a "high" calcium score indicates greater likelihood of disease and may be consistent with moderate to high risk of a cardiovascular event during that time period.
MESA is an ongoing, prospective cohort study that is systematically obtaining information about cardiovascular events that occur after the baseline examination. Future analyses will determine the predictive power of specific CAC scores and percentiles in the 4 racial/ethnic groups. Raggi et al16 found that age- and gender-specific percentiles were more predictive of incident events than the absolute calcium score. It is currently unknown whether there is also effect modification by race/ethnicity. For example, there is evidence that blacks have higher rates of coronary heart disease events despite having less CAC.20 If calcium does have a different impact on risk depending on race, then the observed CAC should be evaluated relative to subjects of the same age, gender, and race/ethnicity, as presented here. It is premature to use percentiles from either this study or others to make medical decisions. In other words, at this time, the information presented here cannot necessarily be used to conclude that a patient is "high risk" but can indicate whether they have a high calcium score relative to others with the same age, gender, and race/ethnicity.
|
Acknowledgments |
|---|
This research was supported by contracts N01-HC-95159 through N01-HC-95165 and N01-HC-95169 from the National Heart, Lung, and Blood Institute. We thank the other investigators, the staff, and the participants of MESA for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org.
Disclosures
None.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990; 15: 827–832.[Abstract]
2. O’Rourke RA, Brundage BH, Froelicher VF, Greenland P, Grundy SM, Hachamovitch R, Pohost GM, Shaw LJ, Weintraub WS, Winters WL. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol. 2000; 36: 326–340.
3. Bild DE, Detrano R, Peterson D, Guerci A, Liu K, Shahar E, Ouyang P, Jackson S, Saad MF. Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2005; 111: 1313–1320.
4. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, Greenland P, Jacobs DR, Kronmal R, Liu K, Clark Nelson J, O’Leary D, Saad MF, Shea S, Szklo M, Tracy RP. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol. 2002; 156: 871–881.
5. Carr JJ, Nelson JC, Wong ND, McNitt-Gray M, Arad Y, Jacobs DR Jr, Sidney S, Bild DE, Williams OD, Detrano R. Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) Study. Radiology. 2005; 234: 35–43.
6. Nelson JC, Detrano R, Kronmal RA, Carr JJ, McNitt-Gray MF, Wong N, Loria C, Goldin JG, Williams DO. Measuring coronary calcium on CT images adjusted for attenuation differences. Radiology. 2005; 235: 403–414.
7. Detrano RC, Anderson M, Nelson J, Wong ND, Carr JJ, McNitt-Gray M, Bild DE. Coronary calcium measurements: effect of CT scanner type and calcium measure on rescan reproducibility: MESA study. Radiology. 2005; 236: 477–484.
8. Cleveland WS, Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc. 1979; 74: 829–836.[CrossRef]
9. O’Brien PC, Dyck PJ. Procedures for setting normal values. Neurology. 1995; 45: 17–23.
10. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2004.
11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001; 285: 2486–2497.
12. Schmermund A, Mohlenkamp S, Berenbein S, Pump H, Meobus S, Roggenbuck U, Stang A, Seibel R, Gronemeyer D, Jockel KH, Erbel R. Population-based assessment of subclinical coronary atherosclerosis using electron-beam computed tomography. Atherosclerosis. July 7, 2005. DOI: 10.1016/j.atherosclerosis.2005.06.003. Available at: http://www.sciencedirect.com. Accessed September 27, 2005.
13. Hoff JA, Chomka EV, Krainik AJ, Daviglus M, Rich S, Kondos G. Age and gender distributions of coronary artery calcium detected by electron beam tomography in 35,246 adults. Am J Cardiol. 2001; 87: 1335–1339.[CrossRef][Medline] [Order article via Infotrieve]
14. Schmermund A, Erbel R, Silber S. Age and gender distribution of coronary artery calcium measured by four-slice computed tomography in 2,030 persons with no symptoms of coronary artery disease. Am J Cardiol. 2002; 90: 168–173.[CrossRef][Medline] [Order article via Infotrieve]
15. Janowitz WR, Agatston AS, Kaplan G, Viamonte M Jr. Differences in prevalence and extent of coronary artery calcium detected by ultrafast computed tomography in asymptomatic men and women. Am J Cardiol. 1993; 72: 247–254.[CrossRef][Medline] [Order article via Infotrieve]
16. Raggi P, Callister TQ, Cooil B, He Z, Lippolis NJ, Russo D, Zelinger A, Mahmarian JJ. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation. 2000; 101: 850–855.
17. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA. 2004; 291: 210–215.
18. Rumberger JA, Sheedy PF, Breen JF, Schwartz RS. Electron beam computed tomographic coronary calcium score cutpoints and severity of associated angiographic lumen stenosis. J Am Coll Cardiol. 1997; 29: 1542–1548.[Abstract]
19. Rumberger JA, Brundage BH, Rader DJ, Kondos G. Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc. 1999: 74; 243–252.[Abstract]
20. Doherty TM, Tang W, Detrano RC. Racial differences in the significance of coronary calcium in asymptomatic black and white subjects with coronary risk factors. J Am Coll Cardiol. 1999; 34: 787–794.
 |
|
 |
|
  R. O. Bonow Should Coronary Calcium Screening Be Used in Cardiovascular Prevention Strategies? N. Engl. J. Med., September 3, 2009; 361(10): 990 - 997. [Full Text] [PDF]
|
|
|
|
 |
|
 N. R. Cook and M. A. Albert Regarding REGARDS: Does Inflammation Explain Racial and Regional Differences in Cardiovascular Disease Risk? Clin. Chem., September 1, 2009; 55(9): 1603 - 1605. [Full Text] [PDF]
|
|
|
|
 |
|
 B. H. Brundage Don't throw the baby out with the bath water. J. Am. Coll. Cardiol., August 4, 2009; 54(6): 574 - 574. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Bastarrika, C. Thilo, G. F. Headden, P. L. Zwerner, P. Costello, and U. J. Schoepf Cardiac CT in the Assessment of Acute Chest Pain in the Emergency Department Am. J. Roentgenol., August 1, 2009; 193(2): 397 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Budoff, R. L. McClelland, H. Chung, N. D. Wong, J. J. Carr', M. M. Gray, R. S. Blumenthal, and R. C. Detrano Reproducibility of Coronary Artery Calcified Plaque with Cardiac 64-MDCT: The Multi-Ethnic Study of Atherosclerosis Am. J. Roentgenol., March 1, 2009; 192(3): 613 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Budoff, K. Nasir, R. L. McClelland, R. Detrano, N. Wong, R. S. Blumenthal, G. Kondos, and R. A. Kronmal Coronary Calcium Predicts Events Better With Absolute Calcium Scores Than Age-Sex-Race/Ethnicity Percentiles MESA (Multi-Ethnic Study of Atherosclerosis). J. Am. Coll. Cardiol., January 27, 2009; 53(4): 345 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. I. Pollin, C. M. Damcott, H. Shen, S. H. Ott, J. Shelton, R. B. Horenstein, W. Post, J. C. McLenithan, L. F. Bielak, P. A. Peyser, et al. A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection Science, December 12, 2008; 322(5908): 1702 - 1705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Erbel, J. A.C. Delaney, N. Lehmann, R. L. McClelland, S. Mohlenkamp, R. A. Kronmal, A. Schmermund, S. Moebus, N. Dragano, A. Stang, et al. Signs of subclinical coronary atherosclerosis in relation to risk factor distribution in the Multi-Ethnic Study of Atherosclerosis (MESA) and the Heinz Nixdorf Recall Study (HNR) Eur. Heart J., November 2, 2008; 29(22): 2782 - 2791. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-s. Jiang, L. Lv, C. P. Juergens, S.-l. Chen, D.-j. Xu, and Z.-y. Huang Racial Differences in Coronary Artery Lesions: A Comparison of Coronary Artery Lesions Between Mainland Chinese and Australian Patients Angiology, August 1, 2008; 59(4): 442 - 447. [Abstract] [PDF]
|
|
|
|
|
|
J. H. Ix, M. A. Allison, J. O. Denenberg, M. Cushman, and M. H. Criqui Novel cardiovascular risk factors do not completely explain the higher prevalence of peripheral arterial disease among African Americans. The San Diego Population Study. J. Am. Coll. Cardiol., June 17, 2008; 51(24): 2347 - 2354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. See, J. B. Lindsey, M. J. Patel, C. R. Ayers, A. Khera, D. K. McGuire, S. M. Grundy, and J. A. de Lemos Application of the Screening for Heart Attack Prevention and Education Task Force Recommendations to an Urban Population: Observations From the Dallas Heart Study Arch Intern Med, May 26, 2008; 168(10): 1055 - 1062. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. D. Reaven, N. Emanuele, T. Moritz, R. Klein, M. Davis, K. Glander, W. Duckworth, C. Abraira, and for the Veterans Affairs Diabetes Trial (VADT) Proliferative Diabetic Retinopathy in Type 2 Diabetes Is Related to Coronary Artery Calcium in the Veterans Affairs Diabetes Trial (VADT) Diabetes Care, May 1, 2008; 31(5): 952 - 957. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Wolak, H. Gransar, L. E.J. Thomson, J. D. Friedman, R. Hachamovitch, A. Gutstein, L. J. Shaw, D. Polk, N. D. Wong, R. Saouaf, et al. Aortic size assessment by noncontrast cardiac computed tomography: normal limits by age, gender, and body surface area. J. Am. Coll. Cardiol. Img., March 1, 2008; 1(2): 200 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Schroeder, S. Achenbach, F. Bengel, C. Burgstahler, F. Cademartiri, P. de Feyter, R. George, P. Kaufmann, A. F. Kopp, J. Knuuti, et al. Cardiac computed tomography: indications, applications, limitations, and training requirements: Report of a Writing Group deployed by the Working Group Nuclear Cardiology and Cardiac CT of the European Society of Cardiology and the European Council of Nuclear Cardiology Eur. Heart J., February 2, 2008; 29(4): 531 - 556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Chung, R. L. McClelland, R. Katz, J. J. Carr, and M. J. Budoff Repeatability Limits for Measurement of Coronary Artery Calcified Plaque with Cardiac CT in the Multi-Ethnic Study of Atherosclerosis Am. J. Roentgenol., February 1, 2008; 190(2): W87 - W92. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Y. Wong, N. Cheung, F. M. A. Islam, R. Klein, M. H. Criqui, M. F. Cotch, J. J. Carr, B. E. K. Klein, and A. R. Sharrett Relation of Retinopathy to Coronary Artery Calcification: The Multi-Ethnic Study of Atherosclerosis Am. J. Epidemiol., January 1, 2008; 167(1): 51 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Preis and C. J. O'Donnell Coronary Heart Disease Risk Assessment by Traditional Risk Factors and Newer Subclinical Disease Imaging: Is a "One-Size-Fits-All" Approach the Best Option? Arch Intern Med, December 10, 2007; 167(22): 2399 - 2401. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Erbel, S. Mohlenkamp, G. Kerkhoff, T. Budde, and A. Schmermund Non-invasive screening for coronary artery disease: calcium scoring Heart, December 1, 2007; 93(12): 1620 - 1629. [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Porter, A. Stavroulopoulos, S. D. Roe, K. Pointon, and M. J.D. Cassidy Detection of coronary and peripheral artery calcification in patients with chronic kidney disease stages 3 and 4, with and without diabetes Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3208 - 3213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. I. Parikh, S.-J. Hwang, M. G. Larson, L. A. Cupples, C. S. Fox, E. S. Manders, J. M. Murabito, J. M. Massaro, U. Hoffmann, and C. J. O'Donnell Parental Occurrence of Premature Cardiovascular Disease Predicts Increased Coronary Artery and Abdominal Aortic Calcification in the Framingham Offspring and Third Generation Cohorts Circulation, September 25, 2007; 116(13): 1473 - 1481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Nasir, M. J. Budoff, N. D. Wong, M. Scheuner, D. Herrington, D. K. Arnett, M. Szklo, P. Greenland, and R. S. Blumenthal Family History of Premature Coronary Heart Disease and Coronary Artery Calcification: Multi-Ethnic Study of Atherosclerosis (MESA) Circulation, August 7, 2007; 116(6): 619 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Cassidy-Bushrow, L. F. Bielak, P. F. Sheedy II, S. T. Turner, I. J. Kullo, X. Lin, and P. A. Peyser Coronary Artery Calcification Progression Is Heritable Circulation, July 3, 2007; 116(1): 25 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. W. Smith, B. N. Uchino, C. A. Berg, P. Florsheim, G. Pearce, M. Hawkins, P. N. Hopkins, and H.-C. Yoon Hostile Personality Traits and Coronary Artery Calcification in Middle-Aged and Older Married Couples: Different Effects for Self-Reports Versus Spouse Ratings Psychosom Med, June 1, 2007; 69(5): 441 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Kronmal, R. L. McClelland, R. Detrano, S. Shea, J. A. Lima, M. Cushman, D. E. Bild, and G. L. Burke Risk Factors for the Progression of Coronary Artery Calcification in Asymptomatic Subjects: Results From the Multi-Ethnic Study of Atherosclerosis (MESA) Circulation, May 29, 2007; 115(21): 2722 - 2730. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Macedo, K. Prakasa, C. Tichnell, F. Marcus, H. Calkins, J. A. C. Lima, and D. A. Bluemke Marked Lipomatous Infiltration of the Right Ventricle: MRI Findings in Relation to Arrhythmogenic Right Ventricular Dysplasia Am. J. Roentgenol., May 1, 2007; 188(5): W423 - W427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sanz, P. R. Moreno, and V. Fuster The Year in Atherothrombosis J. Am. Coll. Cardiol., April 24, 2007; 49(16): 1740 - 1749. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Mazzone, P. M. Meyer, G. T. Kondos, M. H. Davidson, S. B. Feinstein, R. B. D'Agostino Sr., A. Perez, and S. M. Haffner Relationship of Traditional and Nontraditional Cardiovascular Risk Factors to Coronary Artery Calcium in Type 2 Diabetes Diabetes, March 1, 2007; 56(3): 849 - 855. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yoshino, M. K. Kuhlmann, P. Kotanko, R. N. Greenwood, R. L. Pisoni, F. K. Port, K. J. Jager, P. Homel, H. Augustijn, F. T. de Charro, et al. International Differences in Dialysis Mortality Reflect Background General Population Atherosclerotic Cardiovascular Mortality J. Am. Soc. Nephrol., December 1, 2006; 17(12): 3510 - 3519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. K Mittal, M. Barbir, and M. Rubens Role of computed tomography in risk assessment for coronary heart disease. Postgrad. Med. J., October 1, 2006; 82(972): 664 - 671. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Crouse III Thematic review series: Patient-Oriented Research. Imaging atherosclerosis: state of the art J. Lipid Res., August 1, 2006; 47(8): 1677 - 1699. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||